229 related articles for article (PubMed ID: 32931666)
41. Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19.
Hur K; Price CPE; Gray EL; Gulati RK; Maksimoski M; Racette SD; Schneider AL; Khanwalkar AR
Otolaryngol Head Neck Surg; 2020 Jul; 163(1):170-178. PubMed ID: 32423368
[TBL] [Abstract][Full Text] [Related]
42. Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study.
Santus P; Radovanovic D; Saderi L; Marino P; Cogliati C; De Filippis G; Rizzi M; Franceschi E; Pini S; Giuliani F; Del Medico M; Nucera G; Valenti V; Tursi F; Sotgiu G
BMJ Open; 2020 Oct; 10(10):e043651. PubMed ID: 33040020
[TBL] [Abstract][Full Text] [Related]
43. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
De Maio A; Hightower LE
Cell Stress Chaperones; 2020 Sep; 25(5):717-720. PubMed ID: 32424591
[No Abstract] [Full Text] [Related]
44. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
Shi S; Qin M; Shen B; Cai Y; Liu T; Yang F; Gong W; Liu X; Liang J; Zhao Q; Huang H; Yang B; Huang C
JAMA Cardiol; 2020 Jul; 5(7):802-810. PubMed ID: 32211816
[TBL] [Abstract][Full Text] [Related]
45. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.
Qin C; Zhou L; Hu Z; Yang S; Zhang S; Chen M; Yu H; Tian DS; Wang W
Stroke; 2020 Jul; 51(7):2219-2223. PubMed ID: 32466735
[TBL] [Abstract][Full Text] [Related]
46. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
47. Association between procalcitonin levels and duration of mechanical ventilation in COVID-19 patients.
Krause M; Douin DJ; Tran TT; Fernandez-Bustamante A; Aftab M; Bartels K
PLoS One; 2020; 15(9):e0239174. PubMed ID: 32946466
[TBL] [Abstract][Full Text] [Related]
48. Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study.
Huang M; Yang Y; Shang F; Zheng Y; Zhao W; Luo L; Han X; Lin A; Zhao H; Gu Q; Shi Y; Li J; Xu X; Liu K; Deng Y; Cao Q; Wang W
Am J Med Sci; 2020 Aug; 360(2):120-128. PubMed ID: 32709280
[TBL] [Abstract][Full Text] [Related]
49. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
Arentz M; Yim E; Klaff L; Lokhandwala S; Riedo FX; Chong M; Lee M
JAMA; 2020 Apr; 323(16):1612-1614. PubMed ID: 32191259
[TBL] [Abstract][Full Text] [Related]
50. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
[TBL] [Abstract][Full Text] [Related]
51. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
[TBL] [Abstract][Full Text] [Related]
52. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
53. [ECMO Therapy in a Case of Severe ARDS Related to COVID-19].
Schmauss M; Müller E; Schwamborn M; Giesa C; Ewig S
Pneumologie; 2020 Jul; 74(7):423-428. PubMed ID: 32674191
[TBL] [Abstract][Full Text] [Related]
54. HBO2 for COVID-19: Clinical trials at clinicaltrials.gov.
Undersea Hyperb Med; 2020; 47(2):299-307. PubMed ID: 32574447
[No Abstract] [Full Text] [Related]
55. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
56. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.
Geier MR; Geier DA
Med Hypotheses; 2020 Jul; 140():109760. PubMed ID: 32344310
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia.
Motta JC; Novoa DJ; Gómez CC; Moreno JM; Vargas L; Pérez J; Millán H; Arango ÁI
Biomedica; 2020 Oct; 40(Supl. 2):116-130. PubMed ID: 33152195
[TBL] [Abstract][Full Text] [Related]
58. Early outcomes with utilization of tissue plasminogen activator in COVID-19-associated respiratory distress: A series of five cases.
Christie DB; Nemec HM; Scott AM; Buchanan JT; Franklin CM; Ahmed A; Khan MS; Callender CW; James EA; Christie AB; Ashley DW
J Trauma Acute Care Surg; 2020 Sep; 89(3):448-452. PubMed ID: 32427774
[TBL] [Abstract][Full Text] [Related]
59. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.
Russo V; Di Maio M; Attena E; Silverio A; Scudiero F; Celentani D; Lodigiani C; Di Micco P
Pharmacol Res; 2020 Sep; 159():104965. PubMed ID: 32474087
[TBL] [Abstract][Full Text] [Related]
60. Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19-related Acute Respiratory Distress Syndrome.
van der Zee P; Somhorst P; Endeman H; Gommers D
Am J Respir Crit Care Med; 2020 Jul; 202(2):280-284. PubMed ID: 32479112
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
